Randomized Controlled Trial
Copyright ©The Author(s) 2024.
World J Clin Cases. May 26, 2024; 12(15): 2578-2585
Published online May 26, 2024. doi: 10.12998/wjcc.v12.i15.2578
Table 1 Baseline characteristics of the participants, n (%)/mean ± SD
Variable
Intervention group (n = 80)
Control group (n = 80)
P value
Age (yr)58.6 ± 9.459.2 ± 10.20.64
Gender0.87
    Male37 (52.9)36 (51.4)
    Female33 (47.1)34 (48.6)
Education level0.76
    Primary school or below15 (21.4)16 (22.9)
    Middle school31 (44.3)30 (42.9)
    High school or above24 (34.3)24 (34.3)
Marital status0.81
    Married or cohabiting64 (91.4)63 (90.0)
    Single, divorced, or widowed6 (8.6)7 (10.0)
Occupation0.69
    Employed or self-employed39 (55.7)37 (52.9)
    Retired or unemployed31 (44.3)33 (47.1)
Smoking status0.92
    Current smoker11 (15.7)10 (14.3)
    Former smoker or never smoker59 (84.3)60 (85.7)
Drinking status0.77
    Current drinker13 (18.6)14 (20.0)
    Former drinker or never drinker57 (81.4)56 (80.0)
    Body mass index (kg/m2)25.4 ± 3.225.7 ± 3.60.54
    Duration of hypertension (yr)8.3 ± 6.48.7 ± 7.20.71
Number of antihypertensive drugs0.83
    One31 (44.3)29 (41.4)
    Two or more39 (55.7)41 (58.6)
    Systolic blood pressure (mmHg)149 ± 14150 ± 150.67
    Diastolic blood pressure (mmHg)91 ± 992 ± 100.59
Medication adherence score
    MMAS-86.2 ± 1.86.3 ± 1.90.68
Self-efficacy score
    SEMCDS68.4 ± 1.768.6 ± 1.80.51
Perceived benefits score
    HHBS16.8 ± 2.416.9 ± 2.60.32
Perceived barriers score
    HHBS11.2 ± 3.111.4 ± 3.30.49
Perceived susceptibility score
    HHBS14.6 ± 2.914.7 ± 3.10.56
Perceived severity score
    HHBS15.4 ± 2.71 .5 ± 2.80.68